Directs the department of health to create a prescription drug inventory database that contains a list of all drugs designated as being currently in shortage by the federal food and drug administration's drug shortages database, and a list of pharmacies in the state where each such drug is currently in stock.
Prohibits drugs from being dispensed unless a licensed pharmacist has verified that: the package contains the drug to be dispensed, whether the drug is packaged in a child-resistant container, whether a stock container is open and the quantity of the drug to be dispensed.
Directs the department of health to report to the legislature on the feasibility of entering into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs; makes related provisions.
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Enacts the "foreign drug transparency act"; requires the disclosure to a health plan, pharmacy and patient whether a prescription drug was manufactured or compounded in a foreign country; whether the prescription was approved by the federal food and drug administration foreign drug inspection program; requires the date of the last inspection of such prescription drug by the federal food and drug administration foreign drug inspection program; requires certain labelling on such drugs.
Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.
Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.
Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.
Relates to reducing the cost of prescription drugs by establishing maximum wholesale drug prices that are the same as the prices in Canada.
Relates to reducing the cost of prescription drugs by establishing maximum wholesale drug prices that are the same as the prices in Canada.